All lobbying filings

Holland & Knight LLP

Holland & Knight LLP filed a Q3 report for Coloplast Corporation on October 7, 2026, reporting $30,000 in lobbying income.

Lobbying for Coloplast Corporation · Medical device development and manufacturing

As filed: HOLLAND & KNIGHT LLP for COLOPLAST CORPORATION.

All filings by Holland & Knight LLP · Everything Coloplast Corporation has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 7, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

Minnesota

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medicare/Medicaid

Legislation and regulatory policy involving the Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program and ostomy/urological supplies.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.